Cholestyramine
Brand names: Cholestyramine Light, Prevalite
At a glance
- Medicare prescriptions, 2024
- 47,591
- Medicare drug cost
- $4.0M
- Average cost per prescription
- $83.28
- Clinicians who prescribed it
- 2,769
Where it is prescribed
List the prescribers in any state, county, city or ZIP code →
What it is used for
1) Cholestyramine for Oral Suspension, USP Light powder is indicated as adjunctive therapy to diet for the reduction of elevated serum cholesterol in patients with primary hypercholesterolemia (elevated low density lipoprotein [LDL] cholesterol) who do not respond adequately to diet. Cholestyramine for Oral Suspension, USP Light powder may be useful to lower LDL cholesterol in patients who also have hypertriglyceridemia, but it
From the FDA-approved prescribing information (label dated June 2026). Full labels on DailyMed (opens in a new tab)
Who prescribes it
- Gastroenterology 25.0%
- Family Medicine 23.1%
- Nurse Practitioners 18.8%
- Internal Medicine 18.5%
- Physician Assistants 7.0%
- General Practice 1.8%
- Geriatric Medicine 1.7%
- Colorectal Surgery 0.5%
- General Surgery 0.5%
- Hospitalist 0.4%
- Hospice & Palliative Medicine 0.3%
- Cardiology 0.3%
All prescribers, by place, name or specialty →
Share of Medicare prescriptions written by each specialty. Select one to list its prescribers.
What it looks like
Pills from 3 makers on file. The same medicine can look different depending on who made it, so check the imprint (the letters and numbers on the pill) with your pharmacist if a refill looks different.
Bryant Ranch Prepack
| Strength | Looks like | Imprint |
|---|---|---|
| 4 g | yellow powder | |
Epic Pharma, LLC
| Strength | Looks like | Imprint |
|---|---|---|
| 4 g | yellow powder | |
Zydus Lifesciences Limited
| Strength | Looks like | Imprint |
|---|---|---|
| 4 g | yellow powder | |
Source: DailyMed (U.S. National Library of Medicine), from each maker’s FDA drug listing. A few makers are shown, not every one. Never take a pill you can’t identify; ask a pharmacist.
Industry payments about this drug
No industry payments to clinicians named this drug in 2025.
Recalls and shortages
Not on the FDA drug shortage list.
No FDA-reported recalls since 2020.
Sources: CMS Medicare Part D Prescribers by Provider and Drug (2024; prescriptions include refills, and CMS hides counts under 11 per prescriber); U.S. Food and Drug Administration, openFDA (drug labels, NDC directory, enforcement reports, drug shortages); CMS Open Payments 2025; ClinicalTrials.gov. General information only, not medical advice; not yet reviewed by our medical reviewer.